The Cult of Ozempic

The Signal Daily

Dec 20 2023 • 9 mins

Science magazine has crowned GLP-1 drugs such as Ozempic and Wegovy as Breakthrough of the Year. In today's episode, we'll dive into whether these drugs can actually deliver on their promise and give doctors a genuinely effective option for treating patients suffering from obesity.

In other news, the controversial chat show Koffee With Karan is rolling in dough.

The Signal Daily is produced in association with IVM.
The episode was researched and written by Anup Semwal
Edited by Venkat Ananth
Produced by Manaswini
Mastered and mixed by Manas and Nirvaan

See omnystudio.com/listener for privacy information.

You Might Like

The Morning Brief
The Morning Brief
The Economic Times
ANI Podcast with Smita Prakash
ANI Podcast with Smita Prakash
Asian News International (ANI)
ThePrint
ThePrint
ThePrint
3 Things
3 Things
Express Audio
FT News Briefing
FT News Briefing
Financial Times
Top of the Morning
Top of the Morning
Mint - HT Smartcast
Economist Podcasts
Economist Podcasts
The Economist
Daybreak
Daybreak
The Ken
Global News Podcast
Global News Podcast
BBC World Service
HT Daily News Wrap
HT Daily News Wrap
Hindustan Times - HT Smartcast
The Daily
The Daily
The New York Times
The Journal.
The Journal.
The Wall Street Journal & Gimlet
WSJ Tech News Briefing
WSJ Tech News Briefing
The Wall Street Journal
WSJ What’s News
WSJ What’s News
The Wall Street Journal
Serial
Serial
Serial Productions & The New York Times